Antibody Production Market Analysis, Segments, Size, Share, Industry Growth and Recent Trends by Forecast to 2028

[ad_1]

Reports and data

Growing prevalence of infectious diseases and increasing focus on the production of therapeutic antibodies for the treatment of cancer and other chronic diseases

NEW YORK, NY, USA, December 4, 2021 /EINPresswire.com/ – -Global antibody production market size is expected to reach $ 33.52 billion in 2028 and register a CAGR of 13.1%, according to the latest Reports and Data report. Key factors such as increasing investment in research and development activities and increasing demand for cost-effective therapeutic treatments are driving the revenue growth of the global market.

Antibodies are widely used in diagnosis, research, and therapy due to key characteristics such as high specificity, binding affinity, and low toxicity. The global antibody production market is driven by key factors including the cessation of monoclonal antibody patents, the gradual government acceptance of various targeted immunotherapies and antibody therapies to treat several chronic diseases like cancer. and rheumatoid arthritis. The rapid growth of the pharmaceutical and biotechnology industry, the increasing adoption of therapeutic proteins, and the availability of improved technology for the production of antibodies are also fueling the growth of the global market.

However, factors such as expensive primary antibodies and low number of commercially available antibody based drugs are expected to hamper the overall market growth during the forecast period.

You have questions ? To request a sample or speak to an expert before purchasing the report, click the link below: https://www.reportsanddata.com/sample-enquiry-form/1404

Market Snapshot:

The pharmaceutical and healthcare industry has grown rapidly in recent years and is expected to experience vast changes due to the current coronavirus outbreak. Factors such as the rapidly changing healthcare and medical sector, improved healthcare infrastructure and facilities, increased healthcare spending, and the growing adoption of telemedicine and outpatient care services are fueling market growth. In addition, increased investment in research and development activities, the growing preference for personalized drugs and point-of-care diagnostics and home care facilities.

Competitive landscape:

The global antibody production market is extremely competitive consisting of several market players operating at the global as well as regional level. The main players are focused on adopting various strategies such as product launches of R&D investment, mergers and acquisitions, partnerships to gain a solid foothold in the market and expand their product portfolio.

The major companies operating in the market and featured in the report include:

Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, Eppendorf AG, Abcam PLC and Sigma Aldrich Corporation are key players operating in the global antibody production market.

Request Discount on Report @ https://www.reportsanddata.com/discount-enquiry-form/1404

Key questions addressed in the report:

• What market size is the global antibody production market expected to reach during the forecast period?
• What factors are expected to hamper the growth of the global market between 2021 and 2028?
• What key factors are predicted to drive the global antibody production market throughout the forecast period?
• Which application segment is expected to register the fastest revenue CAGR during the forecast period?
• Which region is expected to register the fastest revenue CAGR during the forecast period?
• Who are the major players operating in the Global Antibody Production Market?
• What are the main findings of Porter’s five forces analysis and SWOT analysis?

Find the detailed report description, table of contents and table in Figure @ https://www.reportsanddata.com/report-detail/antibody-production-market

Highlights of the report:

• The polyclonal antibody segment is expected to represent significant revenue growth between 2021 and 2028. The high demand for polyclonal antibodies is due to its rapid production, relatively easy purification, cost-effectiveness and high chance of obtaining better antigen response. by producing antibodies in various animals.

• Based on the process, the downstream process is expected to represent lucrative growth throughout the forecast period. The high utilization of chromatography systems for antibody production is a critical factor in driving the revenue growth of the segment. The downstream process is commonly used due to its high precision and efficiency.

• Among the end-use segments, the research institutes segment is expected to represent rapid revenue growth during the forecast period due to increased investment in R&D activities, increased research on genomics and proteomics and the increased focus on identifying new biomarkers.

• North America accounted for the largest share of revenue in 2020 and is expected to maintain its dominant position throughout the forecast period. The presence of dominant pharmaceutical and biotechnology companies, technological advancements, availability of the latest equipment, well-developed healthcare infrastructure and facilities, growing R&D investments and a strong focus on drug discovery are factors keys that are fueling market growth in this region.

• Europe is expected to represent significant revenue growth over the forecast period due to the presence of prominent key players, increasing prevalence of contagious diseases and ongoing research activities.

• The Asia-Pacific antibody production market is expected to register the fastest revenue CAGR during the forecast period. The increasing incidence of various chronic diseases, the improvement of healthcare infrastructure and other facilities, and the increase in research and development activities are some of the factors that are supporting the revenue growth of the Asia-Pacific market. .

For this study, Reports and Data segmented the global antibody production market on the basis of class, process, end use, and region:

Class Outlook (Revenue, USD Billion, 2020 – 2028)

• Monoclonal antibodies
• Polyclonal antibodies
• Murines
• Chimeric
• Humanized

Process Outlook (Revenue, USD Billion, 2020 – 2028)

• Upstream processing
o Bioreactors
 Large-scale bioreactors
 Single-use bioreactors
o Consumables
Media
 Buffers and reagents
o Downstream processing
 Chromatography systems
 Chromatography resins
Filtration
Filtration systems
 Consumables and filtration accessories

End-Use Outlook (Revenue, USD Billion, 2020 – 2028)

• Pharmaceutical and biotechnology companies
• Diagnostic laboratories
• Research institutes
• Others

Regional perspectives:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Request Report Customization @ https://www.reportsanddata.com/request-customization-form/1404

Thanks for reading the research report on Global Antibody Production Market. We also offer the customization of the report according to the client’s requirements. Please log in to learn more about the customization plan and our team will suggest the plan that best suits your needs.

Browse more reports:

Gene Expression Market @ https://www.medgadget.com/2021/10/gene-expression-market-growth-driven-by-rising-need-for-personalized-medicine-reports-and-data.html

In Vitro Diagnostics (IVD) Quality Control Market @ https://www.medgadget.com/2021/10/gene-expression-market-growth-driven-by-rising-need-for-personalized-medicine-reports- and -data.html

Renal Function Testing Market @ https://www.medgadget.com/2021/10/kidney-function-tests-market-growth-driven-by-surging-prevalence-of-chronic-kidney-diseases-reports- and-data .html

Radiotherapy Market @ https://www.medgadget.com/2021/10/increasing-use-of-raditherapy-to-treat-some-cancers-and-as-a-palliative-treatment-to-drive-revenue -growth -of-radiotherapy-market-reports-and-data.html

About reports and data

Reports and Data is a market research and consulting company that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal to locate, target and analyze changes in consumer behavior across demographics, across industries and help customers make smarter business decisions. We offer market intelligence studies ensuring relevant and evidence-based research across multiple industries including healthcare, technology, chemicals, power and energy. We are constantly updating our research offerings to ensure that our clients are up to date with the latest trends that exist in the market. Reports and Data has a solid base of experienced analysts from various fields of expertise.

Tushar Rajput
Reports and data
8008193052 ext.
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn


[ad_2]
Source link

Comments are closed.